BioNxt Solutions (BNXTF)
OTHER OTC:BNXTF

BioNxt Solutions (BNXTF) Income Statement

30 Followers

BioNxt Solutions Income Statement

Last quarter (Q4 2023), BioNxt Solutions's total revenue was C$4.14K, a decrease of -97.56% from the same quarter last year. In Q4, BioNxt Solutions's net income was C$-1.57M. See BioNxt Solutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 206.74KC$ 372.25KC$ 297.44KC$ 286.50KC$ 345.65KC$ 208.12K
Cost of Revenue
--C$ 101.83KC$ 87.02KC$ 0.00-
Gross Profit
C$ 206.74KC$ 372.25KC$ 195.62KC$ 199.48KC$ 345.65K-
Operating Expense
C$ 6.64MC$ 6.78MC$ 6.27MC$ 16.51MC$ 15.15MC$ 7.32M
Operating Income
C$ -6.43MC$ -6.41MC$ -6.08MC$ -16.31MC$ -14.80MC$ -7.12M
Net Non Operating Interest Income Expense
C$ -1.02MC$ -1.04MC$ -1.14MC$ 731.87KC$ -297.08KC$ -105.06K
Other Income Expense
C$ 265.39KC$ 264.98KC$ -705.13KC$ -3.71MC$ -2.15MC$ -492.42K
Pretax Income
C$ -7.80MC$ -7.72MC$ -12.87MC$ -20.75MC$ -17.25MC$ -7.71M
Tax Provision
--C$ -493.91KC$ -110.74KC$ -357.49KC$ -45.02K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -7.80MC$ -7.72MC$ -12.38MC$ -20.64MC$ -16.89MC$ -7.67M
Basic EPS
C$ -0.06C$ -0.08C$ -0.15C$ -0.29C$ -0.30C$ -0.17
Diluted EPS
C$ -0.06C$ -0.08C$ -0.15C$ -0.29C$ -0.30C$ -0.17
Basic Average Shares
C$ 412.67MC$ 99.32MC$ 83.77MC$ 70.23MC$ 57.22MC$ 45.25M
Diluted Average Shares
C$ 412.67MC$ 99.32MC$ 83.77MC$ 70.23MC$ 57.22MC$ 45.25M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 105.59KC$ 105.18K
Total Expenses
C$ 6.64MC$ 6.78MC$ 6.37MC$ -16.60MC$ 15.15MC$ 7.32M
Net Income From Continuing And Discontinued Operation
C$ -7.80MC$ -7.72MC$ -12.38MC$ -20.64MC$ -16.89MC$ -7.67M
Normalized Income
C$ -6.04MC$ -5.58MC$ -6.87MC$ -17.18MC$ -14.79MC$ -7.18M
Interest Expense
----C$ 297.08KC$ 105.06K
EBIT
C$ -6.78MC$ -6.68MC$ -11.73MC$ -20.02MC$ -16.95MC$ -7.61M
EBITDA
C$ -6.61MC$ -6.48MC$ -11.51MC$ -19.19MC$ -16.05MC$ -6.66M
Currency in CAD

BioNxt Solutions Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis